Scandinavian ChemoTech’s product, IQwave 3.0 CE system, can continue to be sold in the EU without being re-certified until 2028
A Change of transition times for legacy products have been published by the European Committee (EC). This gives medical device products, approved according to the Medical Devices Directive (MDD) requirements, a possibility to continuously be released on the market for a certain time, depending on their risk class. For Scandinavian ChemoTech, this implies that the IQwave 3.0 CE system can be placed on the market for another five years, without renewed certification.The IQwave system is classified to IIb which extends this period until December 31, 2028, when the new European Medical Device